Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine

Clinical trial NCT00315081 · UNKNOWN

Trial details

NCT number: NCT00315081
Sponsor: University Hospital, Bonn
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Hyperprolactinemia

Start date: 2006-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.